Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosbank merges with Tinkoff

3/14/24 ROSB

TCS Group reported for 2023 by IFRS

3/14/24 T

Moscow Exchange set the date for the start of trading in shares of ICJSC TCS Holding

3/14/24 T

brainbox.VC reached important milestones

3/14/24 OTCI

Magnit scales self-service cash desks

3/14/24 MGNT

Yandex.Eda entered the market of Kyrgyzstan

3/14/24 YNDX

Shell still retains the contract to buy LNG from Novatek

3/14/24 NVTK

Aeroflot's passenger turnover in February increased by 23.2%

3/14/24 AFLT

NovaBev reported for 2023 by IFRS

3/14/24 BELU

Moscow Exchange is working to identify unfair practices at auctions

3/14/24 MOEX